Wockhardt's 10-Year Struggle Turns Around With 380% Gains In Samvat 2080: Can A New Antibiotic Restore Its Market Glory?

Wockhardt shares have soared to an 8-year high of Rs 1,212.55, reflecting a remarkable 384% increase since November 10, 2023. The recent surge is largely attributed to the positive recommendation for its new antibiotic, MiqnafTM, by the SEC of CDSCO, aimed at treating Community-Acquired Bacterial Pneumonia.